Annual EBITDA
-$602.13M$75.42M-14.32%
Summary
- Current Value
- As of today, CYTK annual EBITDA is -$602.13M, down -14.32% on
- Historical Performance
- CYTK annual EBITDA is down -90.67% over the past 3 years, down -553.70% over the past 5 years
- All-Time High Comparison
- CYTK annual EBITDA is currently -2243.36% below its historical high of $28.09M set on
- 3-Year Low Comparison
- CYTK annual EBITDA is at its 3-year low
- Sector Comparison
- CYTK annual EBITDA is higher than 1.12% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$602.13M | -14.3% | -90.7% | -553.7% | -1161.4% | |
| Quarterly EBITDA | -$180.24M | -17.6% | -48.1% | -349.8% | -1491.0% | |
| TTM EBITDA | -$629.04M | -13.1% | -74.2% | -515.3% | -1230.7% | |
| Price | $71.48 | +122.8% | +88.1% | +250.1% | +776.0% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $88.04M | +376.6% | -6.9% | +57.7% | +3316.3% | |
| Annual EPS | -$6.54 | -24.1% | -50.9% | -231.3% | -41.5% | |
| -$612.26M | -14.2% | -88.8% | -551.7% | -1133.5% | ||
| Annual Net Income | -$784.96M | -33.1% | -101.8% | -516.7% | -1492.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$315.80M | N/A | -90.7% |
| 5Y | -$92.11M | N/A | -553.7% |
| All | $28.09M | -2243.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$602.13M | at low | |
| 5Y | -$602.13M | at low | |
| All | -$602.13M | at low |
EBITDA History
FAQ
What is the current annual EBITDA of CYTK?
As of today, CYTK annual EBITDA is -$602.13M
What is 1-year change in CYTK annual EBITDA?
CYTK annual EBITDA is down -14.32% year-over-year
What is 3-year change in CYTK annual EBITDA?
CYTK annual EBITDA is down -90.67% over the past 3 years
How far is CYTK annual EBITDA from its all-time high?
CYTK annual EBITDA is currently -2243.36% below its historical high of $28.09M set on December 31, 2009
How does CYTK annual EBITDA rank versus sector peers?
CYTK annual EBITDA is higher than 1.12% of companies in Healthcare sector
When is CYTK next annual earnings release?
As of today, the next annual earnings release for CYTK has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$180.24M$4.74M-2.70%
Summary
- Current Value
- As of today, CYTK quarterly EBITDA is -$180.24M, down -2.70% on
- Historical Performance
- CYTK quarterly EBITDA is down -17.55% year-over-year, down -48.11% over the past 3 years
- All-Time High Comparison
- CYTK quarterly EBITDA is currently -410.16% below its historical high of $58.11M set on
- 3-Year Low Comparison
- CYTK quarterly EBITDA is at its 3-year low
- Sector Comparison
- CYTK quarterly EBITDA is higher than 0.83% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$180.24M | -2.7% | -17.6% | -48.1% | -349.8% | |
| Annual EBITDA | -$602.13M | – | -14.3% | -90.7% | -553.7% | |
| TTM EBITDA | -$629.04M | -4.5% | -13.1% | -74.2% | -515.3% | |
| Price | $71.48 | +14.9% | +122.8% | +88.1% | +250.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $19.36M | +9.0% | +1125.8% | +319.6% | +195.6% | |
| Quarterly EPS | -$1.67 | -11.8% | -22.7% | -21.1% | -152.6% | |
| -$183.62M | -2.9% | -18.0% | -47.5% | -352.1% | ||
| Quarterly Net Income | -$206.03M | -12.6% | -27.7% | -56.9% | -337.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$109.22M | -65.0% | |
| 3Y | -$109.22M | -65.0% | |
| 5Y | -$8.87M | -1931.6% | |
| All | $58.11M | -410.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$180.24M | at low | |
| 3Y | -$180.24M | at low | |
| 5Y | -$180.24M | at low | |
| All | -$180.24M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CYTK?
As of today, CYTK quarterly EBITDA is -$180.24M
What is CYTK quarterly EBITDA most recent change?
CYTK quarterly EBITDA was down -2.70% on March 31, 2026
What is 1-year change in CYTK quarterly EBITDA?
CYTK quarterly EBITDA is down -17.55% year-over-year
How far is CYTK quarterly EBITDA from its all-time high?
CYTK quarterly EBITDA is currently -410.16% below its historical high of $58.11M set on June 30, 2009
How does CYTK quarterly EBITDA rank versus sector peers?
CYTK quarterly EBITDA is higher than 0.83% of companies in Healthcare sector
When is CYTK next earnings release?
The next earnings release for CYTK is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$629.04M$26.91M-4.47%
Summary
- Current Value
- As of today, CYTK TTM EBITDA is -$629.04M, down -4.47% on
- Historical Performance
- CYTK TTM EBITDA is down -13.11% year-over-year, down -74.15% over the past 3 years
- All-Time High Comparison
- CYTK TTM EBITDA is currently -2239.53% below its historical high of $29.40M set on
- 3-Year Low Comparison
- CYTK TTM EBITDA is at its 3-year low
- Sector Comparison
- CYTK TTM EBITDA is higher than 0.83% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$629.04M | -4.5% | -13.1% | -74.2% | -515.3% | |
| Annual EBITDA | -$602.13M | – | -14.3% | -90.7% | -553.7% | |
| Quarterly EBITDA | -$180.24M | -2.7% | -17.6% | -48.1% | -349.8% | |
| Price | $71.48 | +14.9% | +122.8% | +88.1% | +250.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $105.82M | +20.2% | +450.6% | +7.9% | +80.7% | |
| TTM EPS | -$6.84 | -4.7% | -28.9% | -49.4% | -240.0% | |
| -$640.25M | -4.6% | -13.2% | -72.7% | -514.5% | ||
| TTM Net Income | -$829.61M | -5.7% | -34.8% | -92.6% | -514.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$537.60M | -17.0% | |
| 3Y | -$361.20M | N/A | -74.2% |
| 5Y | -$102.23M | N/A | -515.3% |
| All | $29.40M | -2239.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$629.04M | at low | |
| 3Y | -$629.04M | at low | |
| 5Y | -$629.04M | at low | |
| All | -$629.04M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CYTK?
As of today, CYTK TTM EBITDA is -$629.04M
What is CYTK TTM EBITDA most recent change?
CYTK TTM EBITDA was down -4.47% on March 31, 2026
What is 1-year change in CYTK TTM EBITDA?
CYTK TTM EBITDA is down -13.11% year-over-year
How far is CYTK TTM EBITDA from its all-time high?
CYTK TTM EBITDA is currently -2239.53% below its historical high of $29.40M set on September 30, 2009
How does CYTK TTM EBITDA rank versus sector peers?
CYTK TTM EBITDA is higher than 0.83% of companies in Healthcare sector
When is CYTK next earnings release?
The next earnings release for CYTK is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- CYTK Official Website www.cytokinetics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
- CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
- CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk